Compound details
4-(1-Methylethenyl)benzaldehyde
| Compound ID | CDAMM02947 |
|---|---|
| Common name | 4-(1-Methylethenyl)benzaldehyde | IUPAC name | 4-prop-1-en-2-ylbenzaldehyde |
| Molecular formula | C10H10O |
| Retention time | 14.27 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 147.079 | Theoretical mz | 147.08 |
| Error | 11.4 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.8048 |
| Inchi key | IRWAASJGTLXGMV-UHFFFAOYSA-N |
|---|---|
| Smiles | O=CC1=CC=C(C=C1)C(=C)C |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P11509 | CYP2A6 | Cytochrome P450 2A6 | T06455 | SEA |
| P80404 | ABAT | Gamma-amino-N-butyrate transaminase | T59045 | SEA |
| P51649 | ALDH5A1 | Succinate semialdehyde dehydrogenase | T13259 | SEA |
| Q9C000 | NLRP1 | NLR pyrin domain containing 1 | T86910 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T06455 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P11509 | CYP2A6 |
| T06455 | DI0351 | Psoriasis | [ICD-11: EA90] | P11509 | CYP2A6 |
| T59045 | DI0060 | Brain cancer | [ICD-11: 2A00] | P80404 | ABAT |
| T59045 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P80404 | ABAT |
| T59045 | DI0135 | Epileptic encephalopathy | [ICD-11: 8A62] | P80404 | ABAT |
| T59045 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P80404 | ABAT |
| T59045 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P80404 | ABAT |
| T13259 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P51649 | ALDH5A1 |
| T13259 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P51649 | ALDH5A1 |